-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfram Resources Confirms Talks to Acquire Ellipses Pharma, Suspends Trading

MT Newswires·11/16/2026 05:34:32
Listen to the news
05:34 AM EST, 11/16/2026 (MT Newswires) -- Wolfram Resources (WFR.L) is in discussions to potentially acquire Ellipses Pharma, prompting the company to request the suspension of its listing and trading on the London stock exchange, effective Monday. The proposed acquisition would count as an initial transaction under the UK Financial Conduct Authority's Listing Rules, as Wolfram is categorized as a shell company. The suspension is expected to remain in place until the acquisition is completed or the company announces that the deal will not proceed. If completed, Wolfram plans to cancel its existing listing and apply for admission of its enlarged share capital to the commercial companies category.